04.11.2024

Dragos Damian, CEO of Terapia Cluj, announced in an interview with ZF the company has over EUR10 million worth of investments underway in new manufacturing technologies, expansion of end product more

03.14.2023

Terapia Cluj, a local pharmaceutical producer held by India’s Sun Pharma, wants to expand its warehousing area and has a EUR3 million budget to this end. more

07.27.2022

Dragos Damian, CEO of Terapia Cluj, wants to drive the pharmaceuticals producer to RON1 billion turnover in financial year 2022-2023, meaning an over 15% increase vs the previous financial year, in more

05.27.2022

Terapia Cluj, a local pharmaceuticals producer held by pharmaceuticals giant Sun Pharma, has acquired the Uractiv product range of the portfolio of Iasi-based company Fiterman Pharma, according to an more

03.03.2022

Dragos Damian, CEO of one of Romania’s major drug makers, Terapia Cluj, says the company plans to carry out investments worth EUR5.5-5.8 million in Romania. more

02.16.2022

Terapia Cluj, one of the largest pharmaceuticals manufacturers in Romania, has an investment budget of EUR5.5 million for the 2022-2023 financial year and seeks to bring ten new drugstores to its more

05.24.2021

Romanian cosmetics manufacturer Farmec Cluj will make its packaging lines available to medicine producer Terapia Cluj for the manufacturing of hand sanitizer. more

10.26.2020

Generics producer Terapia Cluj, owned by India's Sun Pharma, will have a new country manager starting November 1 – Bogdan Ungureanu, while CEO Dragos Damian will also be leading Sun Pharma's more

06.04.2020

Terapia Cluj, the largest pharmaceutical manufacturer in Romania, ended 2019 with RON736 million revenue, slightly higher than in 2018, Finance Ministry data show. more

05.30.2018

Pharmaceutical manufacturer Terapia based in Cluj, part of India’s Sun Pharma group, posted 671 million lei (EUR145 million) revenue in 2017, 18% higher than in 2016 and had 867 employees. more

05.19.2017

Pharmaceutical manufacturer Terapia based in Cluj, part of India’s Sun Pharma group, posted almost 143 million lei (EUR31 million) net profit last year, an increase of 45% on 2015, according to the more

09.23.2016

Pharmaceutical drug manufacturer Terapia Cluj, a member of the Indian pharmaceutical group Sun Pharma, has boosted share of over-the-counter drugs to 50% of its product portfolio, double as much as in more

04.14.2016

more

04.24.2015

Cluj-based Terapia, the largest local drug producer, posted net profit worth 86 million lei (EUR19 million) last year, down 21% against 2013. This is the first decline the drug maker has witnessed in more

03.26.2015

Sun Pharma group, founded by Dilip Shanghvi, one of India’s wealthiest businessmen, generates sales of over $100 million in Romania, the second largest market in Europe after Russia. Romania is also more

08.04.2014

Romanian pharmaceutical company Terapia Ranbaxy, the largest local generic drug producer, reported sales of around 238 million lei (EUR53.6 million) locally in the first half of 2014, up 9.5% on the more

04.16.2014

Terapia Ranbaxy, the largest pharmaceutical producer in Romania, posted 109 million lei (EUR24.4 million) net profit last year, up nearly 13% from 2012, and a 20% profit margin. Revenue overshot the more

04.15.2014

Sun Pharmaceutical, the Indian company that took over Ranbaxy, owner of Terapia plant, Romania’s largest drug maker, sees “tremendous” growth potential in Romania in the coming period, when the more

03.06.2014

Romania’s largest generic drug maker Terapia Ranbaxy, the local unit of Indian pharmaceuticals group Ranbaxy Laboratories, will pay out its shareholders a total dividend of 205 million lei (EUR45.6 more

02.09.2014

Romanian pharmaceutical company Terapia Ranbaxy, the largest local generic drug producer, reported a turnover of RON 450 million (EUR100.4 million) on the local market in 2013, up 7.5% on the year, more

11.08.2013

Terapia Ranbaxy, the largest generic drug producer in Romania, will invest 29.2 million lei (almost EUR6.6 million) in a research and development center in Cluj-Napoca (NW Romania) to make new types more

11.05.2013

Romanian pharmaceutical company Terapia Ranbaxy, the largest local generic drug producer, registered a growth of around 5% in turnover in the third quarter, to RON110 million (EUR24.7 million), driven more

09.02.2013

Romania is a key market for the Indian pharmaceutical producer Ranbaxy, which owns Terapia Cluj plant in this country, its chief executive officer and managing director Arun Sawhney says. Ranbaxy more

08.09.2013

Romanian pharmaceutical company Terapia Ranbaxy, the largest local generic drug producer, registered turnover of 250 million lei (EUR56 million) in the first half of 2013, up 8% on the year. more

05.09.2013

Sales of Terapia Ranbaxy, Romania’s biggest generic drugs producer, increased some 10% in the first quarter of the year, to RON111 million, with the launch of new products and a higher emphasis on more